These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24461673)

  • 21. Enzyme-linked Immunoassay Index for Anti-NC16a IgG and IgE Auto-antibodies Correlates with Severity and Activity of Bullous Pemphigoid.
    Kalowska M; Ciepiela O; Kowalewski C; Demkow U; Schwartz RA; Wozniak K
    Acta Derm Venereol; 2016 Feb; 96(2):191-6. PubMed ID: 25791894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.
    Berkani N; Joly P; Golinski ML; Colliou N; Lim A; Larbi A; Riou G; Caillot F; Bernard P; Bedane C; Delaporte E; Chaby G; Dompmartin A; Hertl M; Calbo S; Musette P
    Sci Rep; 2019 Mar; 9(1):3525. PubMed ID: 30837635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
    Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
    Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
    [No Abstract]   [Full Text] [Related]  

  • 24. Paraneoplastic bullous pemphigoid: clinical disease activity correlated with enzyme-linked immunosorbent assay index for the NC16A domain of BP180.
    Song HJ; Han SH; Hong WK; Lee HS; Shin JH; Choi GS
    J Dermatol; 2009 Jan; 36(1):66-8. PubMed ID: 19207441
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
    Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
    Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localized pemphigoid (pretibial type) with IgG antibody to BP180 NC16a domain successfully treated with minocycline and topical corticosteroid.
    Kakurai M; Demitsu T; Azuma R; Yamada T; Suzuki M; Yoneda K; Ishii N; Hashimoto T
    Clin Exp Dermatol; 2007 Nov; 32(6):759-61. PubMed ID: 17725660
    [No Abstract]   [Full Text] [Related]  

  • 28. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two cases of childhood bullous pemphigoid.
    Toyama T; Nakamura K; Kuramochi A; Ohyama B; Hashimoto T; Tsuchida T
    Eur J Dermatol; 2009; 19(4):368-71. PubMed ID: 19451055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
    J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.
    Tukaj S; Grüner D; Zillikens D; Kasperkiewicz M
    Cell Stress Chaperones; 2014 Nov; 19(6):887-94. PubMed ID: 24796797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease.
    Sitaru C
    J Invest Dermatol; 2009 Apr; 129(4):822-4. PubMed ID: 19322161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.
    Kamata M; Asano Y; Shida R; Maeda N; Yoshizaki A; Miyagaki T; Kawashima T; Tada Y; Sato S
    J Dermatol; 2019 Jun; 46(6):e216-e217. PubMed ID: 30628103
    [No Abstract]   [Full Text] [Related]  

  • 35. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile.
    Schachter M; Brieva JC; Jones JC; Zillikens D; Skrobek C; Chan LS
    J Am Acad Dermatol; 2001 Nov; 45(5):747-54. PubMed ID: 11606928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332.
    Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M
    J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid.
    Chiavérini C; Hamel-Teillac D; Gilbert D; Prost Y
    Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.
    Sakai A; Shimomura Y; Ansai O; Saito Y; Tomii K; Tsuchida Y; Iwata H; Ujiie H; Shimizu H; Abe R
    Br J Dermatol; 2017 Feb; 176(2):541-543. PubMed ID: 27714780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.